Proliferative changes of renal arteriolar walls induced by administration of angiotensin II receptor blocker are frequent in juvenile rats

被引:5
|
作者
Nagai, Yohko [1 ,2 ]
Nakanishi, Kazushige [2 ]
Akimoto, Tatsuo [2 ]
Yamanaka, Nobuaki [1 ]
机构
[1] Tokyo Kidney Res Inst, Tokyo 1130023, Japan
[2] Toho Univ, Fac Med, Dept Gen Med & Emergency Care, Tokyo, Japan
关键词
Renal pathology; afferent arteriole; smooth muscle cell hyperplasia; angiotensin II receptor blocker; juvenile; SMOOTH-MUSCLE-CELLS; ESSENTIAL-HYPERTENSION; ANTIHYPERTENSIVE TREATMENT; ENDOTHELIAL DYSFUNCTION; JUXTAGLOMERULAR CELLS; ANTAGONIST; HYPERTROPHY; RENIN; DIFFERENTIATION; HYPERPLASIA;
D O I
10.1177/1470320313502105
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Introduction: Our previous study of angiotensin II receptor blocker (ARB) administration in rats induced unusual proliferative changes of smooth muscle cells in renal arteriolar walls. The present study examined if the incidence of the changes depended on the rats' age, and how long it would take to find changes. Materials and methods: Six-week-old (juvenile spontaneous hypertensive rats (SHRs)+ARB group, n=15) and 20-week-old (adult SHRs+ARB group, n=10) male SHRs were fed a standard diet (0.4% NaCl) containing valsartan (10 mg/kg/day; Novartis Co.). Fifteen age-matched SHRs were studied as controls. After 4, 8, and 12 weeks, the rat kidneys were examined under light and electron microscopes and through immunohistochemical studies. Results: Extremely concentric proliferative changes in afferent arteriolar walls were frequently observed in the juvenile SHR+ARB group compared to the adult SHR+ARB group (48.76.8% vs 19.3 +/- 6.9%; p=0.0307) at the 12(th) week. Increased renin expression and arteriolar changes were found from the 4(th) week in the juvenile SHR+ARB group. Conclusion: This study indicates that ARB administration induces unusual proliferative changes and a marked renin-producing cell increase in afferent arterioles more frequently in juveniles than adult rats. It is suggested that the treatment of ARB in juveniles might have a higher risk of changes in renal afferent arterioles.
引用
收藏
页码:440 / 449
页数:10
相关论文
共 50 条
  • [1] Changes in renal vessels following the long-term administration of an angiotensin II receptor blocker in Zucker fatty rats
    Nakanishi, Kazushige
    Nagai, Yohko
    Piao, Honglan
    Akimoto, Tatsuo
    Kato, Hirohito
    Yanakieva-Georgieva, Nadezhda
    Ishikawa, Yukio
    Yoshihara, Kastunori
    Ito, Kinji
    Yamanaka, Nobuaki
    Oite, Takashi
    JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM, 2011, 12 (02) : 65 - 74
  • [2] Angiotensin II receptor blocker pretreatment of rats undergoing sudden renal ablation
    Park, Hye Won
    Kim, Youngki
    Kim, Kee Hyuck
    Rozen, Silvia
    Najafian, Behzad
    Mauer, Michael
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2012, 27 (01) : 107 - 114
  • [3] Severe angioedema induced by angiotensin II receptor blocker
    Hamasaki, Hidetaka
    Hiraishi, Chika
    Yanai, Hidekatsu
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2013, 168 (01) : E15 - E16
  • [4] Effects of angiotensin II receptor blocker on proteinuria in renal transplant recipients
    Tanji, N
    Ohoka, H
    Shimamoto, K
    Ikeda, T
    Miyauchi, Y
    Yokoyama, M
    IN VIVO, 2004, 18 (04): : 433 - 436
  • [5] Renal arteriolar contractile responses to angiotensin II in rats with poorly controlled diabetes mellitus
    Carmines, PK
    Ohishi, K
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 1999, 26 (11): : 877 - 882
  • [6] Improvement of renal function by angiotensin II receptor blocker in patients with essential hypertension
    Watanabe, S
    Okura, T
    Takata, Y
    Miyoshi, K
    Higaki, J
    AMERICAN JOURNAL OF HYPERTENSION, 2003, 16 (05) : 103A - 103A
  • [7] Angiotensin II receptor blocker irbesartan attenuates cardiac dysfunction induced by myocardial infarction in the presence of renal failure
    Watanabe, Ryo
    Suzuki, Jun-ichi
    Wakayama, Kouji
    Kumagai, Hidetoshi
    Ikeda, Yuichi
    Akazawa, Hiroshi
    Komuro, Issei
    Isobe, Mitsuaki
    HYPERTENSION RESEARCH, 2016, 39 (04) : 237 - 244
  • [8] Angiotensin II receptor blocker irbesartan attenuates cardiac dysfunction induced by myocardial infarction in the presence of renal failure
    Ryo Watanabe
    Jun-ichi Suzuki
    Kouji Wakayama
    Hidetoshi Kumagai
    Yuichi Ikeda
    Hiroshi Akazawa
    Issei Komuro
    Mitsuaki Isobe
    Hypertension Research, 2016, 39 : 237 - 244
  • [9] Angiotensin-II receptor blocker exerts cardioprotection in diabetic rats exposed to hypoxia
    Inamoto, Sakiko
    Hayashi, Tetsuya
    Tazawa, Naoko
    Mori, Tatsuhiko
    Yamashita, Chika
    Nakano, Daisuke
    Matsumura, Yasuo
    Okuda, Nobuaki
    Sohmiya, Koichi
    Sakai, Akiko
    Furuya, Eisuke
    Kitaura, Yasushi
    CIRCULATION JOURNAL, 2006, 70 (06) : 787 - 792
  • [10] Effects of olmesartan medoxomil as an angiotensin II-receptor blocker in chronic hypoxic rats
    Nakamoto, T
    Harasawa, H
    Akimoto, K
    Hirata, H
    Kaneko, H
    Kaneko, N
    Sorimachi, K
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2005, 528 (1-3) : 43 - 51